Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Cannabidiol

EU orphan designation number: EU/3/16/1718   
Active ingredient: Cannabidiol
Indication: Treatment of graft-versus-host disease
Sponsor: Salzman Group Ltd
Flat 5, 131 Fellows Road, London NW3 3JJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2016 Orphan designation EMA/OD/110/16 (2016)5625 of 29/08/2016
18/07/2018 Transfer of orphan designation EMA/OD/110/16/T/01 (2018)4807 of 16/07/2018